Peripheral Blood Hematopoietic Stem Cells for Transplantation of Hematological Diseases from Related, Haploidentical Donors after Reduced-Intensity Conditioning

Switzer, 2013, Race and ethnicity in decisions about unrelated hematopoietic stem cell donation, Blood, 121, 1469, 10.1182/blood-2012-06-437343 Pidala, 2012, Race/ethnicity affects the probability of finding an HLA-A, -B, -C and –DRB1 allele-matched unrelated donor and the likelihood of subsequent transplant utilization, Bone Marrow Transplant, 48, 346, 10.1038/bmt.2012.150 O’Donnell, 2002, Non myeloablative bone marrow transplantation from partially HLA-mismatched related donors using post transplantation cyclophosphamide, Biol Blood and Marrow Transplant, 8, 377, 10.1053/bbmt.2002.v8.pm12171484 Luznik, 2008, HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide, Biol Blood and Marrow Transplant, 14, 641, 10.1016/j.bbmt.2008.03.005 Brunstein, 2011, Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts, Blood, 118, 282, 10.1182/blood-2011-03-344853 Baldomero, 2011, The EBMT activity survey 2009: trends over the past 5 years, Bone Marrow Transplant, 46, 485, 10.1038/bmt.2011.11 2005, Allogeneic peripheral blood-stem cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials, J Clin Oncol, 23, 5074, 10.1200/JCO.2005.09.020 Mielcarek, 2012, Long term outcomes after transplantation of HLA-identical related G-CSF mobilized peripheral blood mononuclear cells versus bone marrow, Blood, 119, 2675, 10.1182/blood-2011-12-396275 Hassan, 1996, Comparison of the content and subpopulations of CD3- and CD34- positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors, Transpl Immunol, 4, 319, 10.1016/S0966-3274(96)80054-2 Cutler, 2001, Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem cell and bone marrow transplantation: a meta-analysis, J Clin Oncol, 19, 3685, 10.1200/JCO.2001.19.16.3685 Flowers, 2002, Comparison of chronic graft versus host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow up of a randomized trial, Blood, 100, 415, 10.1182/blood-2002-01-0011 Eapen, 2007, Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft versus host disease without improved survival, Biol Blood Marrow Transplant, 13, 1461, 10.1016/j.bbmt.2007.08.006 Anasetti, 2012, Peripheral blood stem cells versus bone marrow from unrelated donors, New Engl J Med, 367, 1487, 10.1056/NEJMoa1203517 Kasamon, 2010, Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttrasplantation cyclophosphamide: effect of HLA disparity on outcome, Biol Blood Marrow Transplant, 16, 482, 10.1016/j.bbmt.2009.11.011 Prezepiorka, 1995, 1994 Consensus conference on acute GVHD grading, Bone Marrow Transplant, 15, 825 Filipovich, 2005, National Institute of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report, Biol Blood Marrow Transplant, 11, 945, 10.1016/j.bbmt.2005.09.004 Kaplan, 1958, Non-parametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452 Gooley, 1999, Estimation of failure probabilities in the presence of competing risks: New representations of old estimators, Stat Med, 18, 695, 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O Martin, 2004, Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation, Biol Blood and Marrow Transplant, 10, 320, 10.1016/j.bbmt.2003.12.304 Hockenbery, 2007, A randomized, placebo-controlled trial of oral beclomethasone diproprionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease, Blood, 109, 4557, 10.1182/blood-2006-05-021139 Grosso, 2011, A two-step approach to myeloablative haploidentical stem cell transplantation: a phase I/II trial performed with optimized T cell dosing, Blood, 118, 4732, 10.1182/blood-2011-07-365338 Solomon, 2012, Biol Blood and Marrow Transplant, 18, 1859, 10.1016/j.bbmt.2012.06.019